Coloma Jason V (CIK 1676170) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-05). Recent activity: Sell MAZE (2,439 shares), Sell MAZE (154 shares), Sell MAZE (30,304 shares), Sell MAZE (1,604 shares), Sell MAZE (2,593 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,439 | $65,157 |
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 154 | $4,172 |
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 30,304 | $809,541 |
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,604 | $43,445 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,593 | $77,726 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 30,311 | $907,921 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,597 | $48,606 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,953 | $50,781 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,040 | $53,040 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 23,865 | $621,674 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 6,090 | $159,537 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 553 | $14,511 |
| 2026-05-27 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 4,504 | $117,104 |
| 2026-05-27 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,478 | $64,428 |
| 2026-05-27 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 25,582 | $665,516 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,822 | $47,372 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 116 | $3,016 |
Source: SEC Form 4 filings · as of 2026-08-05